
Structural Heart Disease Minimally Invasive Intervention Product Developer

Recently, Vickor Medical officially launched the ISO/IEC 17025 accreditation project, aiming to elevate the technical capabilities and management standards of its testing and calibration laboratories to international levels. Sun Ming, the company’s R&D Director, Zhang Xiong, the Quality Director, Wang Meiying, the Quality Manager, along with other relevant project participants, attended the meeting.
ISO/IEC 17025 is an international standard published jointly by the International Organization for Standardization (ISO) and the International Electrotechnical Commission (IEC) for the competence of testing and calibration laboratories.Obtained ISO/IEC 17025 accreditation,This means that the laboratory has the technical capability to carry out calibration and testing according to international standards, providing accurate and reliable data, enhancing the laboratory's competitiveness in the calibration/testing market, and earning the trust of government departments and all sectors of society.。

In order to ensure the smooth progress of the project, Mr. He Lijun, a senior expert from Shenzhen CCIC Laboratory, was specially invited to conduct an in-depth and detailed training on the content of ISO/IEC 17025:2017 certification. The training content was comprehensive and systematic, covering the basic knowledge of the standard, the writing specifications of management system documents, the preparation methods of the new version of the quality management system documents, as well as the processes, strategies, and practical skills of internal audits.
Vickor's R&D Director, Sun Ming, stated:“Launching the ISO/IEC 17025 accreditation project not only vividly demonstrates our pursuit of excellence and continuous innovation but also represents a significant opportunity to comprehensively enhance the company's R&D capabilities, testing proficiency, cross-departmental collaboration, and management efficiency. We firmly believe that through the implementation of this project, Vickor will provide global patients with even more superior and reliable products and services.” Zhang Xiong, Director of the Quality Department, also expressed high appreciation for the launch of this project and promised to fully support its in-depth advancement.
As an innovative R&D enterprise in the field of cardiovascular and cerebrovascular diseases, particularly in the minimally invasive interventional treatment of heart failure and structural heart disease, Vickor has been committed to developing comprehensive and integrated solutions for the treatment of cardiovascular and cerebrovascular diseases since its establishment.With the launch of this ISO/IEC 17025 accreditation project, the company will further strengthen the laboratory's infrastructure and refined management, comprehensively enhancing technical capabilities and service quality.At the same time, Vickor will actively participate in multilateral cooperation and exchanges for international laboratory accreditation, jointly promoting the continuous advancement of laboratory technology and management standards.
